Sources / An organisation's own page

Tempus AI

1 record was read from this source, dated 21 Sep 2026.

Its permanent copy is being made in the Wayback Machine.

Last checked 21 Sep 2026

What was read from it

Records read from this source
Record	Kind	As stated	Dated
Tempus AI to Recursion Pharmaceuticals: Extension to November 2029 of the 2023 data licence for Tempus's de-identified clinical and molecular records; discretionary fees are replaced by committed payments. Separately Recursion licenses its RNA foundation model TxFM to Tempus (no price in the release).	Licensing deal	Committed payments of $42 million over the next three years, replacing discretionary…	21 Sep 2026

Figures it feeds